Healthcare -
Biotechnology - NASDAQ - US
$ 0.1523
8.71 %
$ 5.55 M
Market Cap
-0.18
P/E
VINC - COST OF REVENUE
Cost of Revenue VINC - Vincerx Pharma, Inc.
915 K
LAST VALUE
64.05%
2 YEAR CAGR
0.00%
5 YEAR CAGR
0.00%
10 YEAR CAGR